MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT

LIVE

Serial Number

90454793

Owner

The American Society of Gene & Cell Therapy

Attorney

Patrick M Bergin

First Use Date

Jan 31, 2014

Filing Date

Jan 8, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT Trademark

Serial Number: 90454793 • Registration: 6920628

MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT is a trademark filed by The American Society of Gene & Cell Therapy on January 8, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). The application is currently registered and active.

Trademark Classes

Class 9 - Computers & Electronics

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Class 41 - Education & Entertainment

Education; providing of training; entertainment; sporting and cultural activities

Owner Contact Info

The American Society of Gene & Cell Therapy (5 trademarks)

20800 Swenson Drive, Suite 300
Waukesha, WI 53186

Entity Type: 03

Legal Representation

Attorney of Record

Patrick M Bergin

1,083 trademarks filed View all →

Correspondence Address

Patrick M Bergin VON BRIESEN & ROPER, S.C.

411 E. WISCONSIN AVENUE

SUITE 1000

MILWAUKEE

WI 53202

Trademark Details

Filing Date

January 8, 2021

Registration Date

December 13, 2022

First Use Anywhere

January 31, 2014

First Use in Commerce

January 31, 2014

Published for Opposition

September 27, 2022

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 13, 2022 NRCC

REGISTERED-PRINCIPAL REGISTER

Dec 13, 2022 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 27, 2022 NPUB

PUBLISHED FOR OPPOSITION

Sep 27, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 7, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 23, 2022 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 25, 2021 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 25, 2021 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 25, 2021 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 24, 2021 GNRN

NON-FINAL ACTION E-MAILED

Apr 24, 2021 GNRT

NON-FINAL ACTION WRITTEN

Apr 24, 2021 CNRT

ASSIGNED TO EXAMINER

Apr 22, 2021 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 8, 2021 NWOS

NEW APPLICATION ENTERED

Jan 12, 2021 NWAP

Related Trademarks

More from this Owner

MOLECULAR THERAPY ONCOLYTICS

MOLECULAR THERAPY NUCLEIC ACIDS

More in Same Class

AVERBA

VALLOOP

Serial #90456037

DIFEISI

RINGBELL

FARMHQ